Phylagen Receives Rigorous AOAC Validation for COVID-19 Indoor Test™


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Phylagen Receives Rigorous AOAC Validation for COVID-19 Indoor Test™
Phylagen recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Test™ that detects SARS-CoV-2 in any built environment.

Phylagen, the San Francisco-based biotech company focused on decoding the environmental microbiome for indoor safety was recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Test™ that detects SARS-CoV-2 in any built environment. Phylagen's test is one of the first to pass the rigorous independent evaluation required by the AOAC Research Institute's Performance Tested Methods™ Program and is currently the only certified SARS-CoV-2 indoor test kit solution available for anyone to purchase directly online.

Phylagen partnered with AOAC INTERNATIONAL at the beginning of the pandemic to be one of the first companies to undergo the rigorous test. During this initial validation process, the Phylagen COVID-19 Indoor Test™ and two other kits were evaluated for detection of the virus. To date, there has been no third-party certification available for indoor environmental testing.

"The rigor the AOAC brings makes it significant for Phylagen to be among the first cohort to receive AOAC's new Certificate of Validation for environmental testing of SARS-CoV-2," said Dr. Brad Taft, Ph.D., Chief Scientific Officer, Phylagen. "The emergence of the AOAC certification reinforces that indoor environmental testing for early detection of COVID-19 is becoming an evermore ubiquitous and essential tool for keeping populations in shared spaces safe."

The COVID-19 Indoor Test™ by Phylagen is a SARS-CoV-2 quantitative detection method that extracts the SARS-CoV-2 RNA from environmental swabs and detects it utilizing RT- PCR technology. Environmental surface swabs are collected by the customer and shipped back to Phylagen, Inc. for sample processing. Sample data are analyzed, and results are reported through a tracking portal.

Since the start of the pandemic, a wide range of businesses has turned to Phylagen to protect their workers by implementing regular indoor environmental testing. Manufacturing facilities shared workspaces, schools, and assisted living homes are just some of the businesses that have partnered with Phylagen to identify the presence of COVID-19.  The COVID-19 Indoor Test™ can be purchased online starting at $189 for five swabs. Custom solutions are also available for purchase. Once Phylagen receives the completed test swabs, results are delivered within 24 hours.  

About Phylagen

Phylagen is a San Francisco based biotech company committed to unlocking the global microbiome of built spaces. Phylagen's internationally recognized team of scientists turn dust into genomic data, providing crucial microbiome insights that impact indoor building health, supply chain traceability, and more.

Tags : #Phylagen #SANFRANCISCO #biotechcompany #AOACINTERNATIONAL #CertificateofValidation #Award #COVID-19IndoorTest #SARS-CoV-2 #ResearchInstitutesPerformanceTestedMethods #Covid-19Test #Covid-19Patients #DailyCovidUpdates

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026